Literature DB >> 12439215

High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk.

Raffaele Bruno, Carmine Gazzaruso, Paolo Sacchi, Cristina Zocchetti, Stefano Giordanetti, Adriana Garzaniti, Valentina Ciappina, Elena Maffezzini, Renato Maserati, Gaetano Filice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12439215     DOI： 10.1097/00126334-200211010-00015

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  11 in total

1.  An increased risk for fractures: another cause of frailty in HIV-infected subjects.

Authors:  Carmine Gazzaruso
Journal:  Endocrine       Date:  2012-06       Impact factor: 3.633

2.  High prevalence of radiological vertebral fractures in HIV-infected males.

Authors:  Carlo Torti; Gherardo Mazziotti; Pier Antonio Soldini; Emanuele Focà; Roberto Maroldi; Daria Gotti; Giampiero Carosi; Andrea Giustina
Journal:  Endocrine       Date:  2011-12-25       Impact factor: 3.633

3.  Coronary Heart Disease (CHD) Risk Factors and Metabolic Syndrome in HIV-Positive Drug Users in Miami.

Authors:  Marianna K Baum; Carlin Rafie; Shenghan Lai; Lihua Xue; Sabrina Sales; J Bryan Page; Ronald Berkman; Linden Karas; Adriana Campa
Journal:  Am J Infect Dis       Date:  2006

Review 4.  Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era.

Authors:  Douglas C MacDonald; Mark Nelson; Mark Bower; Thomas Powles
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 5.  Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV.

Authors:  Raquel Martin-Iguacel; Eugènia Negredo; Robert Peck; Nina Friis-Møller
Journal:  Curr Hypertens Rep       Date:  2016-06       Impact factor: 5.369

Review 6.  HIV therapy, metabolic syndrome, and cardiovascular risk.

Authors:  Vivian Pao; Grace A Lee; Carl Grunfeld
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

7.  Correlation between HIV disease and lipid metabolism in antiretroviral-naïve HIV-infected patients in Japan.

Authors:  Fukuko Oka; Toshio Naito; Miki Oike; Rino Imai; Mizue Saita; Akihiro Inui; Kazunori Mitsuhashi; Hiroshi Isonuma; Takuro Shimbo
Journal:  J Infect Chemother       Date:  2011-07-07       Impact factor: 2.211

8.  HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy.

Authors:  Allison Martin; Cecilia L Moore; Patrick W G Mallon; Jennifer F Hoy; Sean Emery; Waldo H Belloso; Praphan Phanuphak; Samuel Ferret; David A Cooper; Mark A Boyd
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

9.  Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects.

Authors:  Adelzon A Paula; Melissa Cn Falcão; Antonio G Pacheco
Journal:  AIDS Res Ther       Date:  2013-12-13       Impact factor: 2.250

10.  A cross-sectional assessment of metabolic syndrome in HIV-infected people of low socio-economic status receiving antiretroviral therapy.

Authors:  Eduard Tiozzo; Janet Konefal; Sarah Adwan; Lynell A Martinez; Juan Villabona; Johanna Lopez; Stacy Cutrono; Syed Muhammad Ahsan Mehdi; Allan Rodriguez; Judi M Woolger; John E Lewis
Journal:  Diabetol Metab Syndr       Date:  2015-03-07       Impact factor: 3.320
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.